KIDS — OrthoPediatrics Corp. stock price, charts and financials

QT76OrthoPediatrics Corp.

OrthoPediatrics Corp. (NASDAQ: KIDS) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
23.20
+0.43+1.87%
OverviewShort InterestFilings
KIDSQT76OrthoPediatrics Corp.·NASDAQ
23.20+1.87%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CTKB+2.26%$4.29BWAY-0.97%$15.35VREX+48.43%$18.42DCTH+7.08%$16.18TCMD-0.50%$29.35NPCE+0.44%$14.89CBLL+3.11%$19.39BBNX+4.72%$16.65
Snapshot
Index-P/E-EPS (ttm)-1.68Insider Own-Shs Outstand25.68MPerf Week12.78%
Market Cap584.85MForward P/E-EPS next Y-0.81Insider Trans-0.15%Shs Float17.07MPerf Month12.56%
Enterprise Value659.44MPEG-EPS next Q-Inst Own-Short Float5.16%Perf Quarter29.60%
Income-42.75MP/S2.31EPS this Y27.38%Inst Trans-Short Ratio5.39Perf Half Y37.25%
Sales252.73MP/B1.58EPS next Y33.52%ROA-7.77%Short Interest881.26KPerf YTD28.21%
Book/sh-P/C73.36EPS next 5Y-ROE-11.53%52W High23.60 -1.73%Perf Year27.21%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-4.96%52W Low14.69 57.91%Perf 3Y-43.54%
Dividend Est.-EV/EBITDA-Sales past 3/5Y24.60% 27.15%Gross Margin73.65%Volatility6.20% 5.38%Perf 5Y-63.77%
Dividend TTM-EV/Sales2.61EPS Y/Y TTM-2.44%Oper. Margin-9.01%ATR (14)1.07Perf 10Y-
Dividend Ex-Date-Quick Ratio2.17Sales Y/Y TTM18.54%Profit Margin-15.72%RSI (14)72.29Recom2.08
Dividend Gr. 3/5Y-Current Ratio4.78EPS Q/Q-7.69%SMA2012.51%Beta0.99Target Price24.00
Payout0.00%Debt/Eq0.27Sales Q/Q13.46%SMA5017.89%Rel Volume1.18Prev Close22.77
Employees602LT Debt/Eq0.29EarningsOct 27SMA20027.94%Avg Volume166.79KPrice23.20
IPO DateOct 13, 2017Option/ShortYes / YesEPS/Sales Surpr.7.74% 1.85%Net Debt/EBITDA-7.28Volume196,255Change1.87%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-05-26ReiteratedTruist FinancialHold$20 → $22
Aug-05-26ReiteratedPiper SandlerOverweight$22 → $25
May-01-26ReiteratedTruist FinancialHold$20 → $17
Apr-24-26ReiteratedCanaccord Genuity$24 → $25
Dec-10-25ReiteratedCanaccord Genuity$24
Oct-29-25ReiteratedNeedhamBuy$42 → $26
Oct-10-25ReiteratedTruist FinancialHold$22 → $18
Oct-10-25ReiteratedStifel NicolausBuy$32 → $20
Oct-10-25ReiteratedLake StreetBuy$34
Oct-10-25ReiteratedPiper SandlerOverweight$44 → $22
Latest News
Aug-05-26
Aug-05-2609:00AM
Intercontinental Exchange Reports July 2026 Statisticsgurufocus.com
Aug-04-26
Aug-04-2610:20PM
OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcriptseekingalpha.com
08:05PM
OrthoPediatrics Q2 Earnings Call Highlightsmarketbeat.com
08:02PM
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimateszacks.com
04:13PM
OrthoPediatrics Q2 Adj. EPS $(0.26) Beats $(0.30) Estimate, Sales $70.508M Beat $68.247M EstimateBenzinga
04:05PM
OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidanceglobenewswire.com
Jul-30-26
Jul-30-2608:00AM
Intercontinental Exchange to Acquire MarketAxess, Creating a Premier Fixed Income Marketplacegurufocus.com
08:00AM
Intercontinental Exchange Approves Third Quarter Dividend of $0.52 per Sharegurufocus.com
Jul-29-26
Jul-29-2604:05PM
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conferenceglobenewswire.com
Jul-27-26
Jul-27-2605:06PM
12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga
Jul-24-26
Jul-24-2609:00AM
ICE First Look at Mortgage Performance: New Default Activity Posts Annual Decline Led by FHA Loansgurufocus.com
Jul-21-26
Jul-21-2604:05PM
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026globenewswire.com
Jul-16-26
Jul-16-2612:34PM
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $20Benzinga
Jul-14-26
Jul-14-2601:07PM
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for QuotationBenzinga
Jul-06-26
Jul-06-2610:00AM
ICE Mortgage Monitor: Gen Z Accounts for Record 1 in 5 Purchase Mortgage Locksgurufocus.com
Company

OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue253236205——————
Cost of Goods Sold Incl. D&A666456——————
Gross Profit185173149——————
Selling, General and Administrative Excl. Other199193167——————
Research and Development8911——————
Other Operating Expense
200——————
Operating Income-23-29-30——————
Interest Expense963——————
Unusual Expense
—————————
Non-Operating Income (Expense)-7-4-10——————
Net Income Before Taxes-40-39-42——————
Income Taxes00-4——————
Consolidated Net Income-40-40-38——————
Net Income From Continuing Operations-40-40-38——————
Net Income-40-40-38——————
EPS (Recurring)-1.68-1.69-1.64——————
EPS (Basic, Before Extraordinaries)-1.68-1.69-1.64——————
EPS (Diluted)-1.68-1.69-1.64——————
EBITDA-10-12-20——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio2.201.732.60——————
Gross Margin73.1273.3172.68——————
Operating Margin-9.09-12.29-14.63——————
Net Margin-15.81-16.95-18.54——————
Shares Outstanding242323——————
Market Capitalization557408533——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$25.04$22.10$19.16$16.22$13.28● Close Price0.00M0.25M0.50M0.75M1.00MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Odle Gregory APresident of ScoliosisMar 16 '26Sale17.258,433145,469187,735Mar 17
Hite FredCOO and CFOMar 16 '26Sale17.2512,993224,129277,477Mar 17
Gerritzen Daniel JGeneral Counsel and SecretaryMar 16 '26Sale17.258,614148,592149,533Mar 17
Hauser Joseph WPres. Trauma & Def. CorrectionMar 16 '26Sale17.258,596148,281194,767Mar 17
Bailey David RPresident and CEOMar 16 '26Sale17.2519,535336,979298,020Mar 17
Hite FredCOO and CFOAug 21 '25Buy19.415,07698,525213,065Aug 25
Gerritzen Daniel JGeneral Counsel and SecretaryMar 18 '25Sale24.865,310132,007110,767Mar 18
Bailey David RPresident and CEOMar 18 '25Sale24.866,620164,573319,155Mar 18
Hite FredCOO and CFOMar 18 '25Sale24.866,443160,173207,989Mar 18
Odle Gregory APresident of ScoliosisMar 18 '25Sale24.865,359133,225148,788Mar 18
Hauser Joseph WPres. Trauma & Def. CorrectionMar 18 '25Sale24.865,300131,758137,663Mar 18
Gerritzen Daniel JGeneral Counsel and SecretaryAug 21 '24Sale29.3010,000293,00077,304Aug 22
Hite FredCOO and CFOMar 11 '24Sale27.593,19588,15094,072Mar 12
Bailey David RPresident and CEOMar 11 '24Sale27.593,21388,647139,384Mar 12
Gerritzen Daniel JGeneral Counsel and SecretaryMar 11 '24Sale27.592,74175,62452,403Mar 12
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.